11月12日, 南向资金增持昭衍新药10.43万股,连续3日增持。截止当日收盘,港股通共持有昭衍新药4290.37万股,占流通股36.04%。港股通增持金额前五个股分别为中芯国际、建设银行、中升控股、安踏体育、中国神华。昭衍新药近5个交易日上涨8.23%,港股通累计增持179.70万股;近20个交易日上涨22.04%,港股通累计增持192.05万股。|11月12日港股通(深)十大成交榜|||#|...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.